reSee.it - Related Video Feed

The speaker conducted a study on the impact of vaccines on the microbiome. They found a decrease in Bifidobacteria in patients post-vaccination, suggesting a potential link to the vaccine. Further research showed persistent damage to the microbiome even months later. Additionally, newborns of vaccinated mothers had no Bifidobacteria in their microbiome, raising concerns about the transfer of spike proteins through breast milk.

Speaker 0 describes being on the front line in Miami and using vitamin C as a go-to, questioning whether it is taken orally and in what amount. Speaker 1 confirms oral administration and notes taking a lot of vitamin C due to exposure and concern. Speaker 0 explains that a scientist contacted them after testing their sample, asking if they noticed their Bifidobacteria levels had risen fourfold. The speaker reveals they had been taking high dosages of vitamin C, which prompted a shift in approach. While dealing with treating COVID-19 patients and assessing stools in high-risk and severe cases, they decided to consult naturopaths and collect stool samples before and after treatment to evaluate the impact. Speaker 1 recounts that they began making phone calls, offering to pay for stool samples before and after on patients treated with vitamin C. They collected about twenty to twenty-five samples and observed that vitamin C increased Bifidobacteria. This finding led to publishing research showing that vitamin C increases Bifidobacteria in vitro, and they extended this to show an increase in patients as well. Key points: - Vitamin C was used as a primary approach by a frontline clinician in Miami, with emphasis on oral administration. - A scientist noted a fourfold increase in Bifidobacteria, prompting a change in strategy toward investigating vitamin C’s effects. - They initiated a program to collect stool samples before and after vitamin C treatment in COVID-19 patients, collaborating with naturopathic practitioners and funding the stool analyses themselves. - About 20–25 samples were analyzed, revealing that vitamin C increased Bifidobacteria. - They published a paper demonstrating the increase of Bifidobacteria with vitamin C both in vitro and in patient samples.

While treating COVID patients with hydroxychloroquine, the speaker discovered ivermectin's effect on oxygen saturation. This led to the realization that ivermectin is in the same phylum as bifidobacteria, which were found to be lacking in severe COVID cases. Antibiotics are essentially microbes, illustrated by the discovery of penicillin from apple mold killing bacilli. Similarly, vaccines are microbes or pieces of microbes. The speaker notes that drugs are made somehow. Ivermectin is the fermented product of a soil bacteria. The speaker poses the question of whether ivermectin's secretion feeds bifidobacteria, potentially boosting immunity, while emphasizing that this is still under research.

remember, I was the girl that basically was doing clinical trials for pharma, and I was doing fecal transplant. The first thing that came to me during COVID was I bet you it's in the stools. COVID can persist in the stools. Some people were asymptomatic and had COVID in their stools, but yet never had symptoms. What was the difference between those people? The difference was their bifidobacteria. Forty three severe patients with COVID had zero Bifidobacteria. Bifidobacteria was really the beginning for me. It was like, I wonder if that's the microbe I need to focus to neutralize COVID, to suppress COVID. If I have a lot of good bifidobacteria, maybe I'll be fine during COVID. Anecdotal studies like of kimchi and sauerkraut because obviously you can talk to people that ate sauerkraut and still got COVID.

Speaker discusses anecdotal findings on bifidobacteria from vitamin C and ivermectin, and the publish‑or‑perish obstacle in research. "I took a lot of vitamin c at the beginning of the pandemic. Grams a day." "I do not recommend it to anybody." He did it as a guinea pig, and notes that vitamin C "increases bifidobacteria." He then tested about 20 patients to see what happened. "Ivermectin increases bifidobacteria," but publication was blocked by research interference, making long-term effects unclear—"could there be kidney problems? Could there be liver problems?" He laments that you cannot advance research if you don't publish, because publication validates work. When he published "the lost microbes of COVID," labs, Japan, China, and Italy, reproduced the data, confirming replication. "If that paper is real, it gets reproduced into three, four, five papers." He emphasizes colonization as the essence of the work and notes cross‑population questions about who it helps.

Observation: in hypoxic patients, bifidobacteria rise after ivermectin, suggesting a mechanism. With COVID, loss of bifidobacteria is seen in severe or recurrent cases; ivermectin appears to feed bifidobacteria, and oxygen levels improve. 'Crashing oxygen is a huge part of the danger of COVID.' Hypothesis: viruses travel from nose to blood to gut; a study found COVID in the gut, in stool. If COVID is in the gut and ivermectin increases bifidobacteria, the bifidobacteria may take on cytokines, flushing them out, freeing room in the colon to grab cytokines from the body. Cytokine storm—'it's a secretion that basically causes you to have anaphylactic reaction.' Increasing bifidobacteria may liberate cytokines, leading to diarrhea, which is removing the virus from your system. Vitamin C or D or ivermectin associated with diarrhea. The colon evacuates toxins. Data was accurate when I published it. It was retracted after I published it.

The speaker observed that patients with severe COVID were missing bifidobacteria compared to those highly exposed but uninfected. Bifidobacteria is a key microbe for immunity and is present in newborns but absent in older people. The speaker's research indicated vitamin C increases bifidobacteria, which may explain its use for treating colds. Ivermectin also increased bifidobacteria within 24 hours, possibly because it's a fermented product of a similar bacteria. The speaker hypothesized that ivermectin's observed benefits in COVID patients might be due to increased bifidobacteria. This hypothesis was the most read during the pandemic but was later retracted. The speaker believes the retraction of a hypothesis is not in the spirit of science.

The speaker, a gastroenterologist, discusses their research on the microbiome and COVID-19. They found that the virus lingers in stools, hydroxychloroquine kills the virus but harms the microbiome, and bifidobacteria is crucial for immunity. Their studies on vitamin C, ivermectin, and mRNA vaccines' effects on bifidobacteria faced challenges in publication due to going against the mainstream narrative. They highlight the importance of unbiased research and collaboration in finding solutions. The speaker also raises concerns about pharmaceutical companies prioritizing profits over patient safety during the pandemic.

The speaker describes microbiome work on COVID-19 and post-mRNA vaccination, noting profound microbiome effects. “I was the girl that basically was doing clinical trials for pharma, and I was doing fecal transplant.” During COVID, “I bet you it's in the stools.” They found “COVID in the stools in a hundred percent of patients that were positive nasal swab” and that “COVID can persist in the stools.” Some asymptomatic individuals had COVID in stools; “the difference was their bifidobacteria.” Early anecdotal signals about kimchi and sauerkraut are discussed: “What's different between that population? Why is one person eating sauerkraut and kimchi is fine and another person not?” They observed that “forty three severe patients with COVID had zero Bifidobacteria.” They say they will “focus on Bifidobacteria, not the others, because there are some people that have zero bifidobacteria and never got COVID... create a resilience.” Finally, “So bifidobacteria was really the beginning for me. It was like, I wonder if that's the microbe I need to focus to neutralize COVID, to suppress COVID. If I have a lot of good bifidobacteria, maybe I'll be fine during COVID.”

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also discovered that newborns born to vaccinated mothers had no bifidobacteria in their microbiome, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.

Speaker 0 describes starting a microbiome study during vaccine rollout, enrolling doctors who were vaccinated and collecting stool before and after vaccination. The first four patients showed 'the bifidobacteria, this important microbe, is this dropping in patients pre and post vaccination.' As more patients were followed, there was 'killing of the bifidobacteria.' The study was submitted as a poster to the American College of Gastro, where it won the best research award. Colleagues asked how this could happen if vaccines are supposed to improve immunity, and he proposed 'it's creating a bacteriophage or bifidophage.' In four patients for ninety days, bifidobacteria dropped to zero and persisted for six to nine months. They observed no bifidobacteria in newborns from vaccinated, breastfeeding mothers, suggesting 'spike protein going to the breast milk into the baby's gut' might kill the baby's bifidobacteria. They published posters noting loss of bifidobacteria in Crohn's and Lyme patients.

The speaker reflects on the pandemic, describing it as a time of “miracles,” including not losing anyone and continuing to speak today, despite controversy surrounding her research. She emphasizes that the controversy has hindered the advancement of research and science, urging instead to ask questions as science is about questioning and pushing narratives. She asserts a specific finding: the spike protein reduces bifidobacteria. She explains that the vaccine caused bifidobacteria to die within a month, but the effect persisted, with data indicating zero bifidobacteria in long-COVID or vaccine-injured cases. She notes she has been dealing with this for five years and asserts that people with zero bifidobacteria experience ongoing loss of microbiome diversity and immunity, resulting in poor immunity. She highlights bifidobacteria’s role in absorbing sugar, and adds that another microbe responsible for calcium absorption is also destroyed, leading to impaired calcium uptake. From these observations, she links cellular-level consequences to mitochondrial function, describing how a lack of sugar and calcium results in energy shortfalls and a disrupted Krebs cycle, implying mitochondrial dysfunction. She concludes that long COVID is a spike protein injury and that in many cases these individuals have zero bifidobacteria whether due to the treatment, the virus, or the spike protein itself. She also notes that some patients still have residual COVID in their stools, underscoring the need to pay attention to this finding. Key points emphasized: - The pandemic featured perceived miracles and ongoing controversy around research and vaccines, which the speaker argues stifles scientific progress. - A claim that the spike protein reduces bifidobacteria; the vaccine allegedly kills bifidobacteria within a month, with long-COVID or vaccine-injured individuals showing zero bifidobacteria across the line. - Zero bifidobacteria is linked to loss of microbial diversity, compromised immunity, and poor immune function. - Bifidobacteria’s role in absorbing sugar and a related microbe’s role in calcium absorption are highlighted as critical, with their destruction affecting cellular energy and mitochondrial function. - Long COVID is described as a spike protein injury, with some cases having residual COVID in stools, suggesting the need for attention to these microbial findings.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also observed that newborns born to vaccinated mothers had no bifidobacteria in their microbiome, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.

I discovered that patients with severe COVID lacked a key bacteria, bifidobacteria, which is crucial for immunity. Newborns have this bacteria, while the elderly do not due to aging. Vitamin C and Ivermectin were found to increase bifidobacteria levels. I published a hypothesis linking Ivermectin to bifidobacteria increase, which gained attention but was retracted. Hypotheses are essential in science.

The probiotic industry understands the loss of bifidobacterium in cancer and aging populations, but cannot claim probiotics improve longevity due to FDA regulations requiring clinical trials. Doctors also face scrutiny for promoting products without sufficient data. The speaker conducts clinical trials, involving the FDA when bringing products to market, such as ivermectin, doxycycline, and zinc for COVID. Data showed no deaths during treatment, suggesting its effectiveness. Despite a product's market approval with a 20% success rate, the speaker emphasizes the need to address the remaining 80% of patients. Innovation and discussion among doctors are crucial, but social media is now essential for educating doctors and the public due to the high cost of publishing data.

Speaker introduces herself as 'the girl that brought vaccines to market' and cites data that 'the messenger RNA killed the bifidobacteria,' claiming this controversy has halted research and science. She asserts, 'What we discovered with the vaccine is that it did kill the bifida bacteria within a month, persisted in killing the bifida bacteria.' She notes daily reports of 'long COVID or vax' and outlines her interview approach: asking patients if they had COVID, were vaccinated, and whether they contracted COVID after vaccination, concluding 'did the vaccine kill their bifida bacteria.' She describes the immune concept as thinking of the body as 'a group of communities, group of gangs or communities in your gut,' warning that a 'foreigner' prompts autoimmunity. She argues vaccination may 'kill your bifidobacteria,' leading to timing effects on long COVID or vaccine injury, with 'zero bifidobacteria across the line.'

Speaker 0: I had been on the front line in Miami, and my go-to is always vitamin C. Speaker 1: Do you take it orally or is that— Speaker 0: just Orly. Orly. Speaker 1: Orly. Is there a certain amount that you can take orally? Speaker 0: Well, I was taking a lot because I was exposed and I was worried. But then what I realized was I tested my sample, my scientist calls me and he goes, Did you notice your C? Did you notice your Bifidobacteria went up four times the level? What have you been doing? I go, Oh, I’ve been taking high dosages of vitamin C. And then he said to me, Well, you got to look into vitamin C. So right away, I switched my gears. As I’m dealing with treating COVID patients, as I’m dealing at looking at the stools before in high risk and severe, I switched my gears and I said, Okay, we need to call a bunch of naturopaths and send us patients before and after. So I started making phone calls again and said, I’ll pay for stool samples before and after on patients with vitamin C. And then we had like twenty, twenty five samples, and we noticed that the vitamin C increased Bifidobacteria. We published on that because actually vitamin C increases Bifidobacteria in vitro. So we published the paper to show that it increased in patients.

In December 2020, the speaker began collecting stool samples from colleagues before and after their COVID vaccination to study the vaccine's impact on the microbiome. The speaker discovered that mRNA vaccines killed bifidobacteria but believed these findings were unpublishable due to the prevailing narrative. The speaker presented this research as an abstract at the American College of Gastroenterology in October 2022, where it won a research award, beating 6,000 other abstracts. This abstract drew the attention of 18,000 GI doctors, who began to consider that the loss of bifidobacteria may explain why they contracted COVID after vaccination. Further research indicated persistent damage to bifidobacteria from the vaccine. The speaker's presentation also linked the loss of bifidobacteria to Crohn's disease, Lyme disease, and invasive cancer.

Bifidobacteria is presented as a common denominator lacking in individuals with autism, Alzheimer's, cancer, anxiety, bipolar disorder, obesity, and diabetes. The speaker questioned why young people were less affected by COVID-19 compared to older, diabetic, or obese individuals, and also why some seemingly healthy individuals with autoimmune conditions were severely affected. The speaker had pre-pandemic microbiome data and observed a correlation between bifidobacteria levels and COVID-19 outcomes. High-risk individuals exposed to COVID-19 who never contracted the virus had high levels of bifidobacteria, while those who contracted the virus multiple times had zero bifidobacteria. This observation reinforced the importance of bifidobacteria, further emphasized by treatment outcomes.

After observing the vaccine rollout, the speaker began collecting stool samples from vaccinated doctors to analyze the vaccine's impact on the microbiome. Initial analysis of four patients revealed a decrease in Bifidobacteria post-vaccination. This trend continued across 34 patients. The speaker hypothesized that the vaccine might be creating a "Bifidofage." In four patients tracked for 90 days, Bifidobacteria levels dropped from approximately 1,000,000 to zero, and this persisted for up to nine months. The speaker also analyzed the microbiome of newborns breastfed by vaccinated mothers and found an absence of Bifidobacteria, which typically constitutes 90% of a newborn's microbiome. The speaker questions whether the spike protein is transferred through breast milk, impacting the baby's gut and killing the Bifidobacteria.

A top gastroenterologist treated a colleague who became debilitated after vaccination. An examination of her microbiome revealed zero bifidobacteria and actinobacteria. This raised questions about whether the vaccine or spike protein affected her gut microbiome. Similar findings were observed in other vaccine-injured patients, all showing zero bifidobacteria. One patient’s count dropped from one million to zero. This suggests the spike protein, possibly combined with nanoparticles and other contaminants, may enter the bloodstream and affect the gut microbiome, leading to conditions like leaky gut. The implications of these findings remain unpublishable and largely ignored by the medical community.

Dr. Hazen discusses his research on the gut microbiome during the COVID-19 pandemic. He found that the virus lingers in stools and certain treatments affect the microbiome. His studies showed a link between bifidobacteria and COVID-19 outcomes, as well as the impact of mRNA vaccines on bifidobacteria. Despite challenges in publishing data that contradicts the mainstream narrative, he emphasizes the importance of open-mindedness in advancing science and finding solutions.

The speaker, a gastroenterologist, discusses research on the microbiome's role in COVID-19 and challenges encountered publishing findings that contradicted the public health narrative. Early research identified the full viral sequence in stool samples, where it lingered for up to 45 days, and noted hydroxychloroquine and azithromycin killed the virus in stools but harmed the microbiome, leading to the addition of vitamins C, D, and zinc to treatment protocols. An initial FDA exemption for clinical trials using this combination was revoked, and media-fueled fear around hydroxychloroquine hindered recruitment. Research revealed that patients with severe COVID-19 lacked bifidobacteria, a key microbe for immunity, which is abundant in newborns but decreases with age. Vitamin C and ivermectin were found to increase bifidobacteria levels. A hypothesis that ivermectin increased bifidobacteria was retracted after being widely read. Research on mRNA vaccines showed they killed bifidobacteria, a finding presented at a gastroenterology conference and linked to conditions like Crohn's disease, Lyme disease, and invasive cancer. The speaker concludes that interference with research during the pandemic hindered scientific progress and that established clinical trial guidelines were not followed.

The speaker conducted a study on the effects of vaccines on the microbiome. They found that the bifidobacteria, an important microbe for immunity, decreased in patients after vaccination. This led them to suspect that the vaccine may be causing the loss of bifidobacteria. They also observed a lack of bifidobacteria in newborns born to vaccinated mothers, which raised concerns about the spike protein in breast milk. The speaker connected this research to their work on autism, where a loss of bifidobacteria is common. They emphasized the importance of studying the microbiome in various diseases and published posters on the loss of bifidobacteria in Crohn's and Lyme patients. The speaker hopes for further research to prove their hypothesis.